135 related articles for article (PubMed ID: 2683314)
41. Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.
Delsol G; Al Saati T; Gatter KC; Gerdes J; Schwarting R; Caveriviere P; Rigal-Huguet F; Robert A; Stein H; Mason DY
Am J Pathol; 1988 Jan; 130(1):59-70. PubMed ID: 2827494
[TBL] [Abstract][Full Text] [Related]
42. [Study of a monoclonal antibody against new epithelial membrane antigens of transitional cell carcinoma].
Oda H; Hamada H; Nabeshima S; Yokoyama M; Iwata H; Takeuchi M
Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):618-25. PubMed ID: 2197479
[TBL] [Abstract][Full Text] [Related]
43. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
[TBL] [Abstract][Full Text] [Related]
44. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
45. Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
Torenbeek R; Blomjous CE; Quak JJ; Ybema S; Meijer CJ
J Clin Pathol; 1992 Apr; 45(4):303-7. PubMed ID: 1374431
[TBL] [Abstract][Full Text] [Related]
46. [Epithelial membrane antigen in lymphosarcoma cells (immunomorphologic study)].
Smirnov AV; Probatova NA; Sholokhova EN; Petsko AA
Arkh Patol; 1992; 54(2):10-7. PubMed ID: 1524498
[TBL] [Abstract][Full Text] [Related]
47. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
[TBL] [Abstract][Full Text] [Related]
48. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
Tickman RJ; Cohen C; Varma VA; Fekete PS; DeRose PB
Acta Cytol; 1990; 34(4):491-6. PubMed ID: 2197840
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical demonstration of H antigen, peanut agglutinin receptor, and Saphora japonica receptor expression in infant thymuses and thymic neoplasias.
Wiley EL; Nosal JM; Freeman RG
Am J Clin Pathol; 1990 Jan; 93(1):44-8. PubMed ID: 1688483
[TBL] [Abstract][Full Text] [Related]
51. Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers.
Muraoka K; Nabeshima K; Murayama T; Biswas C; Koono M
Int J Cancer; 1993 Aug; 55(1):19-26. PubMed ID: 8344748
[TBL] [Abstract][Full Text] [Related]
52. Epithelial membrane antigen as a marker of human salivary gland acinar and ductal cell function.
Tatemoto Y; Kumasa S; Watanabe Y; Mori M
Acta Histochem; 1987; 82(2):219-26. PubMed ID: 3128050
[TBL] [Abstract][Full Text] [Related]
53. Collision of transitional cell carcinoma and renal cell carcinoma. An immunohistochemical study and review of the literature.
Hart AP; Brown R; Lechago J; Truong LD
Cancer; 1994 Jan; 73(1):154-9. PubMed ID: 7506117
[TBL] [Abstract][Full Text] [Related]
54. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
55. [A case of adenoid cystic carcinoma of the esophagus].
Murao T; Yoshioka H; Sunami M; Saito Y; Fujita T
Gan No Rinsho; 1989 Dec; 35(15):1759-63. PubMed ID: 2558229
[TBL] [Abstract][Full Text] [Related]
56. Human milk-fat globule membrane antigens (Mam-3 group) in normal cycling endometrium and endometrial carcinomas--an immunohistochemical study. A preliminary report.
Ravn V; Jensen H; Hilgers J
APMIS; 1989 May; 97(5):452-8. PubMed ID: 2659045
[TBL] [Abstract][Full Text] [Related]
57. Ki-1 lymphomas in childhood: immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker.
Fujimoto J; Hata J; Ishii E; Kiyokawa N; Tanaka S; Morikawa Y; Shimizu K; Hajikano H
Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):307-14. PubMed ID: 2830712
[TBL] [Abstract][Full Text] [Related]
58. Novel markers of squamous differentiation in the urinary bladder.
Huang W; Williamson SR; Rao Q; Lopez-Beltran A; Montironi R; Eble JN; Grignon DJ; Idrees MT; Emerson RE; Zhou XJ; Zhang S; Baldridge LA; Hahn NM; Wang M; Koch MO; Cheng L
Hum Pathol; 2013 Oct; 44(10):1989-97. PubMed ID: 23806524
[TBL] [Abstract][Full Text] [Related]
59. Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing.
Chopin DK; deKernion JB; Rosenthal DL; Fahey JL
J Urol; 1985 Aug; 134(2):260-5. PubMed ID: 3894692
[TBL] [Abstract][Full Text] [Related]
60. Distribution of epithelial membrane antigen in eccrine poroma.
Takanashi M; Urabe A; Nakayama J; Hori Y
Dermatologica; 1991; 183(3):187-90. PubMed ID: 1720746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
